Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Abbott’s Humira Meets Primary Endpoints in Phase III Study
Abbott’s Humira Meets Primary Endpoints in Phase III Study
Abbott’s Humira Meets Primary Endpoints in Phase III Study
Submitted by
admin
on May 10, 2011 - 10:12am
Source:
Bloomberg
News Tags:
Humira
Abbott Laboratories
ulcerative colitis
Headline:
Abbott’s Humira Meets Primary Endpoints in Phase III Study
Do Not Allow Advertisers to Use My Personal information
